Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.

Hale, D A; Gottschalk, R; Fukuzaki, T; Wood, M L; Maki, T; Monaco, A P

Hale, D A; Gottschalk, R; Fukuzaki, T; Wood, M L; Maki, T; Monaco, A P.

Affiliation

Hale DA; Department of Surgery, Deaconess Hospital, Boston, Massachusetts 02215, USA.

Transplant Proc ; 28(6): 3269, 1996 Dec.

Article in En | MEDLINE | ID: mdl-8962269

Subject(s)

Bone Marrow Transplantation/immunology; Graft Survival/immunology; Immunosuppression Therapy/methods; Immunosuppressive Agents/therapeutic use; Skin Transplantation/immunology; Transplantation, Heterologous/immunology; Transplantation, Homologous/immunology; Animals; Antilymphocyte Serum/therapeutic use; Combined Modality Therapy; Graft Survival/drug effects; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Polyenes/therapeutic use; Rats; Rats, Inbred ACI; Sirolimus

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Heterologous / Transplantation, Homologous / Bone Marrow Transplantation / Immunosuppression Therapy / Skin Transplantation / Graft Survival / Immunosuppressive Agents Limits: Animals Language: En Journal: Transplant Proc Year: 1996 Document type: Article Affiliation country: United States Country of publication: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Search on Google

Add to My VHL

XML

PubMed Links